Forefront Analytics’s Thermo Fisher Scientific TMO Stock Holding History

Forefront Analytics’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$285K	Sell	579 -7	-1%	-$3.8K	0.26%	27
2025 Q4	$339K	Buy	+586	New	+$331K	0.3%	28
2025 Q3	–	Sell	-891	Closed	-$361K	–	45
2025 Q2	$361K	Buy	891 +367	+70%	+$153K	0.4%	26
2025 Q1	$262K	Buy	524 +111	+27%	+$60.1K	0.3%	28
2024 Q4	$215K	Sell	413 -17	-4%	-$9.35K	0.1%	53
2024 Q3	$267K	Sell	430 -26	-6%	-$15.4K	0.13%	54
2024 Q2	$253K	Sell	456 -50	-10%	-$28.6K	0.12%	56
2024 Q1	$295K	Buy	506 +69	+16%	+$38.7K	0.14%	54
2023 Q4	$233K	Buy	+437	New	+$212K	0.11%	54
2023 Q3	–	Sell	-427	Closed	-$223K	–	71
2023 Q2	$223K	Sell	427 -48	-10%	-$25.9K	0.13%	52
2023 Q1	$274K	Buy	+475	New	+$268K	0.14%	56
2022 Q2	–	Sell	-528	Closed	-$317K	–	73
2022 Q1	$317K	Buy	528 +20	+4%	+$11.5K	0.12%	44
2021 Q4	$338K	Buy	508 +14	+3%	+$8.74K	0.11%	42
2021 Q3	$283K	Sell	494 -20	-4%	-$11K	0.1%	46
2021 Q2	$260K	Buy	+514	New	+$243K	0.1%	49

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Forefront Analytics's TMO Position: Q1 2026 in Review

Forefront Analytics reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, selling an estimated $3.8K and leaving 579 shares worth $285K. The position accounts for 0.26% of the portfolio, ranked #27.

Forefront Analytics first reported a position in TMO in Q2 2021 and has held it in 15 quarters since. The position peaked at $361K in Q2 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Forefront Analytics held 579 shares of Thermo Fisher Scientific worth $285K as of Q1 2026.
Forefront Analytics sold 7 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.8K.
Thermo Fisher Scientific made up 0.26% of Forefront Analytics's portfolio in Q1 2026, its #27 holding.
Forefront Analytics first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 15 quarters since.
Forefront Analytics's Thermo Fisher Scientific position peaked at $361K in Q2 2025.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Forefront Analytics's 13F filing for Q1 2026, filed 13 May 2026.